Compass Therapeutics, Inc.
CMPX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001738021
In the last 90 days, Compass Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $363.4M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Compass Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 76 | 1 | 77 | +2 |
| Shares | 89.7M | 2.83M | 86.1M | −779.0K (−0.9%) |
| Value | $176.7M | $5.57M | $134.3M | −$36.8M (−21.5%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Compass Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Blue Owl Capital Holdings LP | 2,829,712 | $4.41M | 1.06% |
| Element Capital Management LLC | 293,888 | $458.5K | 1.55% |
| Pennant Investors, LP | 199,000 | $310.4K | 0.10% |
| Citadel Advisors LLC | 166,137 | $259.2K | 0.00% |
| CM Management, LLC | 125,000 | $195.0K | 0.16% |
| Squarepoint Ops LLC | 88,720 | $138.4K | 0.00% |
| Jane Street Group, LLC | 83,085 | $129.6K | 0.00% |
| Susquehanna International Group, LLP | 65,852 | $102.7K | 0.00% |
| HSBC Holdings PLC | 32,145 | $47.9K | 0.00% |
| Virtu Financial LLC | 28,054 | $44.0K | 0.00% |
| Wexford Capital LP | 12,700 | $19.8K | 0.00% |
| Victory Capital Management Inc | 11,031 | $17.2K | 0.00% |
| Federated Hermes, Inc. | 3,541 | $5.52K | 0.00% |
| Nisa Investment Advisors, LLC | 65 | $101 | 0.00% |
| CWM, LLC | 158 | $0 | 0.00% |
Sold out (13)
Institutions that held Compass Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Foresite Capital Management V, LLC | 1,246,977 | $2.46M |
| Prosight Management, LP | 935,157 | $1.84M |
| Swiss National Bank | 163,400 | $321.9K |
| Alps Advisors Inc | 94,115 | $185.4K |
| Credit Suisse AG | 73,368 | $144.5K |
| Algert Global LLC | 33,963 | $66.9K |
| Salem Investment Counselors Inc | 30,000 | $59.1K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 24,314 | $47.9K |
| Arizona State Retirement System | 21,612 | $42.6K |
| Teacher Retirement System of Texas | 21,566 | $42.0K |
| Verition Fund Management LLC | 15,515 | $30.6K |
| Stifel Financial Corp | 15,000 | $29.6K |
| Flagship Harbor Advisors, LLC | 11,000 | $21.7K |
Not filed for Q4 2023 yet (1)
Institutions that held Compass Therapeutics, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| CHI Advisors LLC | 2,829,712 | $5.57M |